Side-by-side comparison of AI visibility scores, market position, and capabilities
Bengaluru digital gold savings automation via UPI AutoPay for Indian retail investors; YC-backed $14.6M with $7.5M Series A at $4.1M revenue competing with Jar App and PhonePe Gold for automated savings.
Gullak Money is a Bengaluru-based fintech company automating savings and investing them into digital gold through UPI AutoPay — enabling Indian consumers to accumulate gold wealth through systematic small purchases without requiring active investment decisions, addressing the deep cultural affinity for gold savings in India's $800 billion household gold market. Founded in 2022 by Manthan Shah, Dilip Jain, and Naimisha Rao and backed by Y Combinator with $14.6 million raised including a $7.5 million Series A in September 2025, Gullak generated $4.1 million in revenue in 2024 with 1 million+ app downloads on Google Play Store.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.